Byline: Will Doss
-
Drug Protects Neurons in Parkinson’s Disease
Treating mice with isradipine, a calcium channel blocker, prevented formation of toxic compounds that can cause Parkinson’s disease symptoms, according to a recent Northwestern Medicine study.
-
New Technique Helps Uncover Changes in ALS Neurons
Northwestern Medicine scientists used an innovative technique to measure electrical activity in ALS neurons, finding changes in excitability that indicated disease, according to a study published in Stem Cell Reports.
-
Increased Cell Recycling Could Treat Aging-Related Conditions
Enhancing autophagy, the system that recycles old or dysfunctional cells, could have therapeutic effects in a variety of aging-related diseases, according to a pair of Northwestern Medicine studies.
-
Mitochondrial Dysfunction Contributes to Kidney Disease
Lack of a receptor regulating mitochondrial metabolism was linked with kidney dysfunction including kidney disease, according to a recent study.
-
Rare Bacteria Boosts Immunotherapy in Prostate Cancer
A unique bacterial strain isolated from a patient with pelvic pain could be the key to treating prostate cancer with immunotherapy, according to a study published in Nature Communications.
-
Students Look Beyond the Chart at Shirley Ryan AbilityLab
All Feinberg students complete a two-week Physical Medicine and Rehabilitation clerkship at the Shirley Ryan AbilityLab, where they are encouraged to think about their patients’ overall function, rather than just their illness.
-
Early Synaptic Dysfunction Found in Parkinson’s Disease
Genetic mutations dysregulating synapse function contribute to a toxic cascade that leads to neurodegeneration in Parkinson’s disease, according to a Northwestern Medicine study.
-
Exceptional Achievement Recognized at Honors Day 2018
Feinberg faculty and fourth-year medical students gathered to recognize clinical and academic achievement at the sixth annual Honors Day, held May 19.
-
Resetting the Epigenetic Balance for Cancer Therapy
Northwestern Medicine scientists have discovered an epigenetic imbalance that can lead to cancer, and used these findings to inhibit tumors in models.
-
CNADC Celebrates Transformative Gift at Alzheimer Day
Feinberg met its goal of raising $10 million for the newly renamed Mesulam Cognitive Neurology and Alzheimer’s Disease Center, naming the Center after its director, M. Marsel Mesulam, MD.
